President and CEOOfficers of the CorporationBoard of TrusteesLeadership CouncilHistory
Managing DiabetesChildhood DiabetesNutritionExerciseOnline Diabetes ClassesDiscussion BoardsInfo for Healthcare ProfessionalsJoslin Clinical Guidelines50-Year Medalist Program
Adult ClinicPediatricsEye CareBillingInfo for Healthcare ProfessionalsDiabetes Information & Resources
Directory of Joslin InvestigatorsDiabetes Research Center Alumni Connection
Media RelationsNews ReleasesInside JoslinSocial Media
Affiliated CentersPharma & DeviceCorporate EducationPublicationsProfessional EducationInternational
Give NowHow You Can Help JoslinHigh Hopes FundGet InvolvedEventsCorporate & Foundation SupportPlanned GivingPhilanthropy Team

Dan Anderson, Ph.D.

Dr. Anderson has spent the last 10 years developing non-viral gene delivery agents.  These studies have resulted in delivery materials with excellent gene delivery performance in vitro and in vivo.  Products based on these materials have been commercialized specifically to transfect stem cells (Stemfect from Stemgent, Xfect from Clonetech).  He has also spent significant effort towards the in vivo application of DNA and RNA delivery systems, and have demonstrated delivery efficacy in a variety of species, including primates. 

Page last updated: December 17, 2017